Webinar Registration has been closed.
Schedule M—now aligned with WHO, USFDA, EU-GMP, and PIC/S standards—and what it means for your facility.
Learn how to implement core elements like Pharmaceutical Quality Systems (PQS), Quality Risk Management (QRM), and Product Quality Reviews (PQR).
Know exactly what’s required and by when—especially for small and large manufacturers facing the December 2025 deadline.
Understand new requirements for computerized systems, contract manufacturing, and niche products like biologics and radiopharmaceuticals.
We are regulatory solutions provider catering to a vast array of services and products to simplify, familiarize and support our clients through every step of the Regulatory process.
250+

50+ Leaders
In this Upcoming webinar, meet our experts to Understand it and Implement it.

Founder & CEO

Senior Executive- Regulatory affairs

Sr. Manager - Regulatory Affairs
This session is ideal for professionals in pharmaceutical manufacturing—including QA/QC personnel, Regulatory Affairs specialists, Plant Heads, Compliance teams, Validation experts, and pharma entrepreneurs—who need to align with the latest GMP standards under the revised Schedule M.

You’ll gain a clear understanding of the major changes in Schedule M (2023), including Quality Risk Management (QRM), Pharmaceutical Quality Systems (PQS), Product Quality Review (PQR), and new requirements around contract manufacturing, computerized systems, and more.




